CLINICAL_TRIALS
trial_result
· 2016-04-15
Clinical Trial Update: Effect of Glycopyrronium on Morning Symptoms and Pulmonary Function in Patients With Moderate to Severe COPD [Phase 4]
Summary
Phase 4 trial assessing the effect of glycopyrronium on morning COPD symptoms and pulmonary function; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: COPD | Phase 4 | Status: COMPLETED | Results posted: 2016-04-15